TherapeuticsMD (TXMD) Return on Invested Capital (2020 - 2025)

TherapeuticsMD (TXMD) reported Return on Invested Capital of 0.04% for Q3 2025, down 1734.68% quarter-over-quarter from 0.0% in Q2 2025.

TherapeuticsMD (TXMD) Return on Invested Capital (2020 - 2025) Analysis & Trends

TherapeuticsMD has reported Return on Invested Capital for 3 years, with the latest figure at 0.04% in Q3 2025.

For the quarter ending Q3 2025, Return on Invested Capital changed N/A year-over-year to 0.04%; the trailing twelve-month figure through Sep 2025 stood at 0.04% (changed N/A YoY), and the FY2024 full-year result was 0.0%, changed 0.0% from the prior year.
Return on Invested Capital for Q3 2025 stood at 0.04%, down from 0.0% in the prior quarter.
The five-year high for Return on Invested Capital was 0.0% in Q2 2025, with the low at 0.04% in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	0.00%
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	0.01%
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	0.00%
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	0.00%
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	0.00%
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	0.00%
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	0.00%
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	0.00%
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	0.00%
10	TherapeuticsMD	21,180.42	-8.40 Mn	-	-

Download Data